Postoperative Pain and Incidence of Extrusion Following the Use of Two Intra-canal Medications in Retreatment of Single Rooted Teeth
Launched by MINIA UNIVERSITY · Apr 3, 2025
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two different types of medications used during a dental procedure affect pain after treatment and whether they cause any medication to leak outside the intended area. The study focuses on patients who have had previous dental work done on single-rooted teeth that didn't succeed, aiming to find out if the way the medication is applied impacts post-treatment pain or complications.
To be eligible for this trial, you must have had unsuccessful endodontic treatment (a procedure to save a tooth) on a single-rooted tooth and have no other health issues that could affect the study. Unfortunately, if you have teeth with multiple roots, you would not qualify. Participants will receive one of the two medications being tested and will be monitored for any discomfort or side effects afterward. This research hopes to improve how dental retreatments are performed, making them safer and more comfortable for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with failed endodontic treatment in single root teeth
- • Systemic free
- Exclusion Criteria:
- • Muktirooted teeth
About Minia University
Minia University is a prestigious educational institution located in Egypt, dedicated to advancing medical research and clinical trials. With a commitment to fostering innovation and improving healthcare outcomes, the university collaborates with a diverse range of stakeholders, including healthcare professionals and researchers. Minia University aims to enhance clinical practices through rigorous research methodologies and ethical standards, contributing to the body of knowledge in the medical field while addressing local and global health challenges. The university's clinical trial initiatives are designed to evaluate new treatments and interventions, ensuring a positive impact on patient care and community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported